Seeds and phytopharmaceuticals derived from the plant
Ginkgo biloba are
dietary supplements used to improve memory, brain metabolism, and
blood flow, and to treat
neuronal disorders. It has been long used for a wide range of medicinal purposes. For instance, in
Japan and
China,
Ginkgo biloba is used to treat
cough,
bronchial asthma, irritable
bladder and
alcohol use disorder. Ginkgotoxin is found in the seeds and, in lesser amounts, in the leaves of
Ginkgo biloba. The seeds can be consumed as is and the leaves can be used to prepare the dietary supplements. Analyses of raw seeds from eight different locations in Japan by
high-performance liquid chromatography showed concentrations of ginkgotoxin varying from 0.173 to 0.4 mg/g of seeds. Also, there is a
seasonal variation of ginkgotoxin concentration in the seeds. The maximum has been observed in August. Analyses of the powder of
Ginkgo biloba capsules revealed the presence of ginkgotoxin. However, as most oral supplements are made from the leaves, which contain only small amounts of ginkgotoxin, below the level of toxicological relevance. Ginkgotoxin-5'-glucoside is a derivative of ginkgotoxin that possesses a
glycosyl in the 5' position. Its content is higher than the concentration of ginkgotoxin in heated seeds (boiled or roasted). Liberation of ginkgotoxin by
enzymatic hydrolysis of the
glycosidic linkage is possible. Nevertheless, the
toxicity or the mechanism of action of the glucoside form is not fully understood. Ginkgotoxin can also be found in plants of the genus
Albizia. However, these plants have no known dietary use for humans, so their production of ginkgotoxin is of lesser concern. == Biosynthesis ==